We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The vaccine has been approved after meeting the required safety, quality and effectiveness standards.
…Janssen's single-dose COVID-19 vaccine authorised by the Medicines and Healthcare products Regulatory Agency (MHRA).…
First published during the 2019 to 2022 Johnson Conservative government
Change approved following detailed review of additional stability data
The Regulators’ Pioneer Fund will deliver initiatives that will help to keep the UK at the forefront of regulatory thinking and experimentation.
New government-funded clinical trial looking at different COVID-19 ‘booster’ vaccines launches in the UK
New government-funded clinical trial looking at different COVID-19 ‘booster’ vaccines launches in the UK.
More than 36 million people in the UK have been vaccinated with 1 dose and 20 million have received 2 doses.
The public has until 3 June to respond to the consultation on the potential reclassification of Nuromol to a general sale list medicine.
More than 35 million people have been vaccinated with a first dose of a coronavirus (COVID-19) vaccine.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the UK government on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40.
UK medicines regulator issues its first authorisation under Project Orbis for Osimertinib (Tagrisso), a post-surgery treatment for lung cancer.
New state-of-the-art labs will test the effectiveness of vaccines against new variants.
Dr Alison Cave joins the Medicines and Healthcare products Regulatory Agency (MHRA) as Chief Safety Officer
More than 34 million people have had at least one jab while 15 million have had both doses of the vaccine.
The doses will be used alongside other vaccines to support preparations for a booster programme from the autumn.
Real-world data shows hospitalisations and deaths from COVID-19 are falling significantly due to the vaccine roll-out.
Today the government has published a series of photographs taken by photojournalists working with the NHS, showcasing the people behind the UK-wide vaccination programme -- ahead of a campaign urging under-50s to get the jab.
The milestone means almost 1 in 5 adults have received both vaccines.
The JCVI has advised that pregnant women should be offered the COVID-19 vaccine at the same time as the rest of the population, based on their age and clinical risk group.
Everybody in cohorts 1 to 9 has been offered a vaccine, with people aged 45 to 49 now invited to book their appointments.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).